Citadel Advisors’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,000
Closed -$1.15M 15475
2025
Q1
$1.15M Buy
38,000
+4,900
+15% +$141K ﹤0.01% 6652
2024
Q4
$941K Buy
33,100
+23,900
+260% +$643K ﹤0.01% 7145
2024
Q3
$240K Buy
9,200
+8,700
+1,740% +$170K ﹤0.01% 9771
2024
Q2
$7.3K Sell
500
-300
-38% -$4.24K ﹤0.01% 13261
2024
Q1
$11.8K Buy
+800
New +$11K ﹤0.01% 13389

Other funds holding AHR

Citadel Advisors's AHR Position: Q1 2026 in Review

Citadel Advisors increased its American Healthcare REIT (AHR) stake by 340% in Q1 2026, buying an estimated $33.6M and bringing the position to 877,170 shares worth $41.4M. The position accounts for 0.01% of the portfolio, ranked #1541.

Citadel Advisors first reported a position in AHR in Q1 2024 and has held it in 8 quarters since. 518 funds tracked by Wall St. Rank hold AHR as of Q1 2026.

  • Citadel Advisors held 877,170 shares of American Healthcare REIT worth $41.4M as of Q1 2026.
  • Citadel Advisors bought 678,001 American Healthcare REIT shares in Q1 2026, an estimated $33.6M.
  • American Healthcare REIT made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1541 holding.
  • Citadel Advisors first reported a position in American Healthcare REIT in Q1 2024 and has held it in 8 quarters since.
  • 518 funds tracked by Wall St. Rank held American Healthcare REIT as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.